Toho Holdings Co., Ltd.

8129.T
Medical Distribution
2026/04/14 Updated
Market Cap: $1.9B (¥296.5B)
Stock Price: $28.68 (¥4,582)
Exchange Rate: 1 USD = ¥159.74

Notice Regarding Extension of the Board of Directors’ Evaluation Period Concerning Large-Scale Purchase Activities of Our Company’s Stock

The company has extended the Board of Directors' evaluation period to April 28, 2026, to consider the appropriateness of large-scale purchase activities by 3D Investment Partners Pte. Ltd.

Importance:
Page Updated: April 10, 2026
IR Disclosure Date: April 10, 2026

Key Figures

  • Board of Directors' Evaluation Period Extended To: April 28, 2026
  • Initial Evaluation Period End Date: April 14, 2026
  • Independent Committee Extension Limit: 20 business days

AI要約

Regarding the Extension of the Board of Directors' Evaluation Period

Toho Holdings Co., Ltd. has decided to extend the Board of Directors' evaluation period, initially set to end on April 14, 2026, to April 28, 2026 in order to secure sufficient time for the provision and careful review of necessary information concerning the large-scale purchase activities by 3D Investment Partners Pte. Ltd. Based on recommendations from the Independent Committee, this extension is reasonably necessary, and the company is proceeding with careful evaluation and consideration.

Future Outlook and Impact on Shareholders

The company plans to announce a new medium-term management plan covering fiscal years 2026 through 2028 on April 28, 2026, emphasizing the presentation of management policies necessary for shareholders to judge the appropriateness of the large-scale purchase activities. The Management Strategy Committee is currently examining measures to maximize corporate value, and attention is focused on forthcoming information disclosures and evaluation outcomes.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.